Inventor
CEE VICTOR J
US33 patents
⚠️ This page may combine multiple inventors who share the name “CEE VICTOR J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
27 patentsUS10640504B2May 5, 2020
Inhibitors of KRAS G12C and methods of using the same
AMGEN INC50 citations97
US10532042B2Jan 14, 2020
KRAS G12C inhibitors and methods of using the same
AMGEN INC49 citations97
US10519146B2Dec 31, 2019
KRAS G12C inhibitors and methods of using the same
AMGEN INC81 citations97
US7560551B2Jul 14, 2009
Aurora kinase modulators and method of use
AMGEN INC61 citations97
US11306087B2Apr 19, 2022
Inhibitors of KRAS G12C and methods of using the same
AMGEN INC16 citations94
US11096939B2Aug 24, 2021
KRAS G12C inhibitors and methods of using the same
AMGEN INC24 citations94
US11090304B2Aug 17, 2021
KRAS G12C inhibitors and methods of using the same
AMGEN INC33 citations94
US11045484B2Jun 29, 2021
KRAS G12C inhibitors and methods of using the same
AMGEN INC24 citations94
US11285135B2Mar 29, 2022
KRAS G12C inhibitors and methods of using the same
AMGEN INC20 citations93
US10988485B2Apr 27, 2021
KRAS G12C inhibitors and methods of using the same
AMGEN INC27 citations92
US7868177B2Jan 11, 2011
Multi-cyclic compounds and method of use
AMGEN INC28 citations92
US11053226B2Jul 6, 2021
KRAS G12C inhibitors and methods of using the same
AMGEN INC25 citations91
US7880000B2Feb 1, 2011
Protein kinase modulators and method of use
AMGEN INC21 citations91
US7776869B2Aug 17, 2010
Heteroaryl-substituted alkyne compounds and method of use
AMGEN INC20 citations91
US11426404B2Aug 30, 2022
Dosing of KRAS inhibitor for treatment of cancers
AMGEN INC19 citations89
US12083121B2Sep 10, 2024
Substituted piperazines as KRAS G12C inhibitors
AMGEN INC7 citations85
US11993597B2May 28, 2024
Inhibitors of KRAS G12C and methods of using the same
AMGEN INC8 citations85
US11905281B2Feb 20, 2024
KRAS G12C inhibitors and methods of using the same
AMGEN INC13 citations85
US11766436B2Sep 26, 2023
KRAS G12C inhibitors and methods of using the same
AMGEN INC11 citations85
US11285156B2Mar 29, 2022
Substituted piperazines as KRAS G12C inhibitors
AMGEN INC16 citations85
US9242961B2Jan 26, 2016
Aurora kinase modulators and method of use
AMGEN INC6 citations84
US8022221B2Sep 20, 2011
Aurora kinase modulators and method of use
AMGEN INC10 citations83
US8772480B2Jul 8, 2014
Inhibitors of PI3 kinase and/or mTOR
AMGEN INC5 citations71
US12440491B2Oct 14, 2025
KRAS G12C inhibitors and methods of using the same
AMGEN INC1 citations64
US12583854B2Mar 24, 2026
KRAS G12C inhibitors and methods of using the same
AMGEN INC0 citations62
US7842685B2Nov 30, 2010
S1P1 receptor agonists and use thereof
AMGEN INC3 citations62
US9365522B2Jun 14, 2016
Pyrazole amide derivative
AMGEN INC2 citations47